<div id="readability-page-1"><div><p>As global markets navigate a mixed landscape, with small-cap and value stocks gaining traction, investors are increasingly looking toward under-the-radar opportunities in Asia. Penny stocks, though often considered a relic of past trading days, still hold potential for significant growth when backed by strong financials. In this article, we explore three Asian penny stocks that stand out for their balance sheet strength and potential to uncover hidden value in today's market.</p><h3>Top 10 Penny Stocks In Asia</h3><table><tbody><tr><td><strong>Name</strong></td><td><strong>Share Price</strong></td><td><strong>Market Cap</strong></td><td><strong>Rewards &amp; Risks</strong></td></tr><tr><td>Lever Style (SEHK:1346)</td><td>HK$1.44</td><td>HK$890.67M</td><td>✅ 4 ⚠️ 1 View Analysis &gt;</td></tr><tr><td>Asia Medical and Agricultural Laboratory and Research Center (SET:AMARC)</td><td>THB2.62</td><td>THB1.1B</td><td>✅ 3 ⚠️ 3 View Analysis &gt;</td></tr><tr><td>TK Group (Holdings) (SEHK:2283)</td><td>HK$2.48</td><td>HK$2.06B</td><td>✅ 4 ⚠️ 1 View Analysis &gt;</td></tr><tr><td>Atlantic Navigation Holdings (Singapore) (Catalist:5UL)</td><td>SGD0.122</td><td>SGD63.87M</td><td>✅ 2 ⚠️ 3 View Analysis &gt;</td></tr><tr><td>Halcyon Technology (SET:HTECH)</td><td>THB2.96</td><td>THB888M</td><td>✅ 2 ⚠️ 3 View Analysis &gt;</td></tr><tr><td>Yangzijiang Shipbuilding (Holdings) (SGX:BS6)</td><td>SGD3.45</td><td>SGD13.58B</td><td>✅ 5 ⚠️ 1 View Analysis &gt;</td></tr><tr><td>Anton Oilfield Services Group (SEHK:3337)</td><td>HK$0.96</td><td>HK$2.54B</td><td>✅ 3 ⚠️ 2 View Analysis &gt;</td></tr><tr><td>NagaCorp (SEHK:3918)</td><td>HK$4.42</td><td>HK$19.55B</td><td>✅ 5 ⚠️ 1 View Analysis &gt;</td></tr><tr><td>Livestock Improvement (NZSE:LIC)</td><td>NZ$1.00</td><td>NZ$137.01M</td><td>✅ 2 ⚠️ 5 View Analysis &gt;</td></tr><tr><td>Bosideng International Holdings (SEHK:3998)</td><td>HK$4.53</td><td>HK$52.62B</td><td>✅ 4 ⚠️ 2 View Analysis &gt;</td></tr></tbody></table><p>Click here to see the full list of 947 stocks from our  Asian Penny Stocks screener.</p><p>Here's a peek at a few of the choices from the screener.</p><h2>LifeTech Scientific (SEHK:1302)</h2><p><strong>Simply Wall St Financial Health Rating:</strong> ★★★★★★</p><p><strong>Overview:</strong> LifeTech Scientific Corporation is an investment holding company that develops, manufactures, and trades interventional medical devices for cardiovascular and peripheral vascular diseases across Mainland China and various international markets, with a market cap of HK$8.38 billion.</p><p><strong>Operations:</strong> The company's revenue is derived from three main segments: Structural Heart Diseases Business (CN¥527.87 million), Peripheral Vascular Diseases Business (CN¥762.08 million), and Cardiac Pacing and Electrophysiology Business (CN¥37.63 million).</p><p><strong>Market Cap:</strong> HK$8.38B</p><p>LifeTech Scientific, with a market cap of HK$8.38 billion, is gaining attention due to recent product approvals and innovations in interventional medical devices. The company has secured regulatory approval for its G-iliac™ Pro stent system and the CS™ Stent-Graft System, which are expected to enhance its product portfolio significantly. Despite a decline in earnings over the past five years and recent negative growth, LifeTech remains debt-free with strong short-term asset coverage over liabilities. However, management's limited tenure may pose challenges as they navigate competitive industry dynamics and aim for revenue growth through innovative solutions.</p><ul><li>Click here to discover the nuances of LifeTech Scientific with our detailed analytical financial health report.</li><li>Examine LifeTech Scientific's past performance report to understand how it has performed in prior years.</li></ul><figure><img height="476" src="https://imageproxy.pbkrs.com/https://images.simplywall.st/company/f4cde0c9-3c8c-4906-8b2c-0faa80c9ae86/chart/debt-equity-history-analysis?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" width="746" original-src="https://imageproxy.pbkrs.com/https://images.simplywall.st/company/f4cde0c9-3c8c-4906-8b2c-0faa80c9ae86/chart/debt-equity-history-analysis"/><figcaption>SEHK:1302 Debt to Equity History and Analysis as at Jan 2026</figcaption></figure><h2>United Energy Group (SEHK:467)</h2><p><strong>Simply Wall St Financial Health Rating:</strong> ★★★★★☆</p><p><strong>Overview:</strong> United Energy Group Limited is an investment holding company involved in upstream oil, natural gas, clean energy, and energy trading operations across Pakistan, South Asia, the Middle East, and North Africa with a market cap of approximately HK$12.41 billion.</p><p><strong>Operations:</strong> The company generates revenue from its trading operations amounting to HK$7.99 billion and exploration and production activities totaling HK$9.13 billion.</p><p><strong>Market Cap:</strong> HK$12.41B</p><p>United Energy Group, with a market cap of HK$12.41 billion, has recently become profitable despite a 19.2% annual decline in earnings over the past five years. The company benefits from strong cash reserves exceeding its total debt and robust interest coverage of 44.4 times EBIT, indicating financial stability amidst volatility reduction from 10% to 5%. However, challenges include an inexperienced management team and board with an average tenure of just 0.6 years, alongside short-term liabilities surpassing assets by HK$1.4 billion and a dividend not well covered by earnings or free cash flows despite high-quality earnings.</p><ul><li>Click to explore a detailed breakdown of our findings in United Energy Group's financial health report.</li><li>Review our historical performance report to gain insights into United Energy Group's track record.</li></ul><figure><img height="476" src="https://imageproxy.pbkrs.com/https://images.simplywall.st/company/2508be64-00a3-48b7-8fbc-63c2c5323748/chart/debt-equity-history-analysis?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" width="746" original-src="https://imageproxy.pbkrs.com/https://images.simplywall.st/company/2508be64-00a3-48b7-8fbc-63c2c5323748/chart/debt-equity-history-analysis"/><figcaption>SEHK:467 Debt to Equity History and Analysis as at Jan 2026</figcaption></figure><h2>InnoTek (SGX:M14)</h2><p><strong>Simply Wall St Financial Health Rating:</strong> ★★★★☆☆</p><p><strong>Overview:</strong> InnoTek Limited is an investment holding company that manufactures precision metal components in Hong Kong, the People’s Republic of China, Thailand, and Vietnam, with a market cap of SGD172.63 million.</p><p><strong>Operations:</strong> The company's revenue is derived from its Mansfield division, with SGD35.04 million from Precision Machining and SGD279.71 million from Precision Components and Tooling.</p><p><strong>Market Cap:</strong> SGD172.63M</p><p>InnoTek Limited, with a market cap of SGD172.63 million, demonstrates financial resilience as its cash reserves exceed total debt and short-term assets cover both long-term and short-term liabilities. However, the company faces challenges with declining earnings over the past five years and low return on equity at 1.5%. The dividend payout is not well covered by earnings despite high-quality earnings overall. Recent board changes may bring strategic shifts but do not immediately address profitability concerns or improve net profit margins, which have decreased from 1.9% to 1.4% over the last year.</p><ul><li>Jump into the full analysis health report here for a deeper understanding of InnoTek.</li><li>Understand InnoTek's track record by examining our performance history report.</li></ul><figure><img height="476" src="https://imageproxy.pbkrs.com/https://images.simplywall.st/company/12da91b7-f162-4c43-bee1-d9294ba5d487/chart/debt-equity-history-analysis?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" width="746" original-src="https://imageproxy.pbkrs.com/https://images.simplywall.st/company/12da91b7-f162-4c43-bee1-d9294ba5d487/chart/debt-equity-history-analysis"/><figcaption>SGX:M14 Debt to Equity History and Analysis as at Jan 2026</figcaption></figure><h2>Turning Ideas Into Actions</h2><ul><li>Click this link to deep-dive into the 947 companies within our  Asian Penny Stocks screener.</li><li>Want To Explore Some Alternatives? Diversify your portfolio with solid dividend payers offering reliable income streams to weather potential market turbulence.</li></ul> <p><em> This article by Simply Wall St is general in nature. <strong>We provide commentary based on historical data      and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice.</strong> It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your      financial situation. We aim to bring you long-term focused analysis driven by fundamental data.      Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material.      Simply Wall St has no position in any stocks mentioned.</em></p></div></div>

01302

01346

02283

<p>As global markets shift, investors are eyeing Asian penny stocks for growth. This article highlights three promising stocks: Lever Style (SEHK:1346) with a market cap of HK$890.67M, Asia Medical and Agricultural Laboratory (SET:AMARC) at THB1.1B, and TK Group (SEHK:2283) valued at HK$2.06B. Each stock shows strong financials and potential for value discovery. Additionally, LifeTech Scientific (SEHK:1302) and United Energy Group (SEHK:467) are noted for their market caps of HK$8.38B and HK$12.41B, respectively, despite facing challenges in earnings and management experience.</p>

3 Asian Penny Stocks With Market Caps Under US$2B